Xuan Wang — Endo Lab

article 2026

Mitofusin 2 Attenuates Adenomyosis Progression by Suppressing Epithelial-Mesenchymal Transition: Evidence From Clinical and Experimental Models

·doi:10.31083/ceog46464

Background: Adenomyosis involves epithelial-mesenchymal transition (EMT), yet the role of mitochondrial regulator Mitofusin 2 (Mfn2) remains unclear. This study investigated the role of Mfn2 in adenomyosis-related EMT and evaluated its pote…

preprint 2025

Molecular classification and clinical significance of endometrial cancer complicated with adenomyosis

·doi:10.21203/rs.3.rs-8222275/v1

Abstract Background/Objectives: To study the molecular classification of endometrial cancer combined with adenomyosis and compare its differences in molecular classification and clinicopathological characteristics with endometriosis ade…

article 2019

[Pharmacological mechanism of Shenghua Decoction in treatment of abdominal pain based on network pharmacology].

·doi:10.19540/j.cnki.cjcmm.20190218.003

The Shenghua Decoction recorded in Fu Qing Zhu's Gynaecology,is a commonly used postpartum prescription,widely used in treating postpartum and gynecological diseases. However,its mechanism of action in treating lower abdominal pain remains …